Abstract
Among diffuse gliomas, oligodendrogliomas may account for 25% of cases. They have a better prognosis and chemosensitivity as compared to astrocytomas. Genetic studies have shown a correlation between oligodendrocyte phenotype and presence of 1p/19q deletions. In addition, these deletions are of prognostic value. The aim of the present study was to describe a new method to detect 1p/19q deletions when little tumoral material is available (stereotactic biopsies (SBs)). Since smears (cytological preparations) are routinely done for intraoperative diagnosis of gliomas, we have searched for 1p/19q deletions by FISH in a series of 30 patients with a glioma. In 14 cases, loss of heterozygosity (LOH) analysis was also performed in order to validate our method. We found that FISH analysis on frozen smears was a simple, rapid and reliable method to detect 1p/19q deletions and a good concordance was found with LOH data (85%). The main advantages of FISH analysis on frozen smears are the following. First, it requires little material and can be easily done in the case of SBs. Second, it has a higher sensitivity than LOH especially in infiltrative areas of gliomas. Third, it allows detection of a codeletion 1p/19q in a single tumor cell.
In contrast, LOH analysis is easier to interpret and can detect smaller and partial deletion whose pronostic significance remains to be defined. In conclusion, these two techniques can be used to investigate 1p/19q status in gliomas. The appropriate choice of one or other of these two techniques will depend on the specific questions that need to be answered.
Similar content being viewed by others
References
Reifenberger G, Kros JM, Schiffer D, Burger PC, Louis DN, Collins VP: Oligodendroglioma. In: Kleihues PK, Cavenee WK (eds) Pathology and Genetics Tumours of the Nervous System. 2nd edn., IARC Press, Lyon, 2000, pp. 56-61
Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, Graeber MB, Bauserman S, Buckner JC, Burton J, Riepe R, Tazelaar HD, Nascimento AG, Crotty T, Keeney GL, Pernicone P, Altermatt H: Oligodroglioma: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60: 248–262, 2001
Bello MJ, Vaquero J, De Campos JM, Kusak E, Sarasa JL, Saez-Castresana J, Pestana A, Rey JA: Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 57: 172–175, 1994
Bello MJ, Leone PE, Vaquero J, De Campos JM, Kusak ME, Sarasa JL, Pestana A, Rey JA: Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenetic events in oligodendroglial tumors. Int J Cancer 64: 207–210, 1995
Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD: Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155: 375–386, 1999
Rasheed BK, Wiltshire RN, Bigner SH, Bigner SH, Bigner DD: Molecular pathogenesis of malignant gliomas. Curr Opin Oncol 11: 162–167, 1999
Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18: 4144–4152, 1999
Smith JS, Jenkins RB: Genetic alterations in adults diffuse glioma: occurrence, significance and prognostic implications. Front Biosci 5: 1, 2000
Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311–1333, 2001
Reifenberger G, Louis DN: Oligodendroglioma: towards molecular definitions in diagnostic neuro-oncology. JNEN 62: 111–126, 2003
Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H: Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Acta Neuropathol (Berl) 103: 267–275, 2002
Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473–1479, 1998
Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18: 636–645, 2000
Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov, Ramsay DA, Cairncross JG, Louis DN: Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7: 839–845, 2001
Hoang-Xuan K, He J, Huguet S, Mokhtari K, Marie S, Kujas M, Leuraud P, Capelle L, Delattre JY, Poirier J, Broët P, Sanson M: Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology 57: 1278–1281, 2001
Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW: Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 8: 1, 2003
Beuvon F, Varlet P, Fallet-Bianco C, Daumas-Duport C: Techniques des smears pour l'examen extemporané: apport en pathologie neurochirurgicale. Ann Pathol 20: 499–506, 2000
Schmidt MC, Antweiler S, Urban N, Mueller W, Meyer-Puttlitz KB, Wiestler OD, Louis DN, Fimmers R, Von Diemling A: Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61: 321–328, 2002
Hatanpaa KJ, Burger PC, Eshelman JR, Murphy KM, Berg KD: Molecular diagnosis of oligodendrogliomas in paraffin sections. Lab Invest 83: 419–428, 2003
Katsetos CD, Del VL, Geddes JF, Path FR, Aldape K, Boyd JC, Legido A, Khalili K, Perentes E, Mörk SJ: Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status. J Neuropathol Exp Neurol 61: 307–320, 2002
Herrlinger U, Felsberg J, Kuker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M: Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 52: 390–399, 2002
Kros JM, Zheng P, Dinjens WN, Alers JC: Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol 61: 806–814, 2002
Mawrin C, Lins H, Kirches WN, Schildhaus HU, Scherlach C, Kanakis D, Dietzmann: Distribution of p53 alterations in a case of gliomatosis cerebri. Hum Pathol 34: 102–106, 2003
Low M, Feiden W, Moringlane JR, Zang KD, Henn W: Detection of numerical chromosome aberrations in brain tumours by fluorescence in situ hybridization on smear preparations of small tumour biopsies. Neuropathol Appl Neurobiol 20: 432–438, 1994
Perry A, Nobori T, Ru N, Anderl K, Borell TJ, Mohapatra G, Feuerstein BG, Jenkins RB, Carson DA: Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. J Neuropathol Exp Neurol 56: 999–1008, 1997
Walker C, Joyce K, Du Plessis D, MacHell Y, Sibson DR, Broome J: Molecular genetic analysis of archival gliomas using diagnostic smears. Neuropathol Appl Neurobiol 26: 441–447, 2000
Kosel S, Graeber MB: Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol (Berl) 88: 19–25, 1994
Srinivasan M, Sedmak D, Jewell S: Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161: 1961–1971, 2002
Jenkins RB, Curran W, Scott CB, Cairncross G: Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a National Cooperative Treatment Group. Am J Clin Oncol 24: 506–508, 2001
Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA: Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens. Mod Pathol 16: 708–715, 2003
Iuchi T, Namba H, Iwadate E, Shishikura T, Kageyama H, Nakamura Y, Ohira M, Yamaura A, Osato K, Sakiyama S, Nakagawara A: Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglioma tumors. Genes Chromosomes Cancer 35: 170–175, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bouvier, C., Roll, P., Quilichini, B. et al. Deletions of Chromosomes 1p and 19q are Detectable on Frozen Smears of Gliomas by FISH: Usefulness for Stereotactic Biopsies. J Neurooncol 68, 141–149 (2004). https://doi.org/10.1023/B:NEON.0000027758.10286.c1
Issue Date:
DOI: https://doi.org/10.1023/B:NEON.0000027758.10286.c1